Multiple sclerosis and COVID-19: A great opportunity for databases promoting research and collaboration

Michael K. Racke; Scott D. Newsome

doi:10.1016/j.jneuroim.2020.577283

Multiple sclerosis and COVID-19: A great opportunity for databases promoting research and collaboration

Michael K. Racke, Scott D. Newsome

School of Medicine

Research output: Contribution to journal › Editorial › peer-review

2 Scopus citations

Original language	English (US)
Article number	577283
Journal	Journal of Neuroimmunology
Volume	345
DOIs	https://doi.org/10.1016/j.jneuroim.2020.577283
State	Published - Aug 15 2020

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Neurology
Clinical Neurology

Access to Document

10.1016/j.jneuroim.2020.577283

Cite this

@article{2ba1a065cf6c4b41a4be5f1409481edc,

title = "Multiple sclerosis and COVID-19: A great opportunity for databases promoting research and collaboration",

author = "Racke, {Michael K.} and Newsome, {Scott D.}",

note = "Funding Information: Dr. Scott Newsome has received consultant fees for scientific advisory boards from Biogen, Genentech, Celgene, EMD Serono, Novartis, is an advisor for BioIncept, a clinical adjudication committee member for a medDay Pharmaceuticals clinical trial and has received research funding (paid directly to institution) from Biogen, Novartis, Genentech, National Multiple Sclerosis Society, Department of Defense, and Patient Centered Outcomes Institute.",

year = "2020",

month = aug,

day = "15",

doi = "10.1016/j.jneuroim.2020.577283",

language = "English (US)",

volume = "345",

journal = "Journal of Neuroimmunology",

issn = "0165-5728",

publisher = "Elsevier",

}

TY - JOUR

T1 - Multiple sclerosis and COVID-19

T2 - A great opportunity for databases promoting research and collaboration

AU - Racke, Michael K.

AU - Newsome, Scott D.

N1 - Funding Information: Dr. Scott Newsome has received consultant fees for scientific advisory boards from Biogen, Genentech, Celgene, EMD Serono, Novartis, is an advisor for BioIncept, a clinical adjudication committee member for a medDay Pharmaceuticals clinical trial and has received research funding (paid directly to institution) from Biogen, Novartis, Genentech, National Multiple Sclerosis Society, Department of Defense, and Patient Centered Outcomes Institute.

PY - 2020/8/15

Y1 - 2020/8/15

UR - http://www.scopus.com/inward/record.url?scp=85085946567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85085946567&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2020.577283

DO - 10.1016/j.jneuroim.2020.577283

M3 - Editorial

C2 - 32518058

AN - SCOPUS:85085946567

SN - 0165-5728

VL - 345

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

M1 - 577283

ER -

Multiple sclerosis and COVID-19: A great opportunity for databases promoting research and collaboration

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this